Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Zydus Lifesciences LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:532321NSE Symbol: ZYDUSLIFEP/E(TTM):36.99
ISIN Demat:INE010B01027Div & Yield %:0.61EPS(TTM):26.71
Book Value(Rs):145.1076344Market Cap ( Cr.):99425.98Face Value(Rs):1
    Change Company 
( In Cr)
 Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
INCOME :      
Sales Turnover 8731.607836.907780.006347.406037.405822.60
Excise Duty0.000.000.000.000.0012.70
Net Sales8731.607836.907780.006347.406037.405809.90
Other Income 548.40178.7089.30908.70605.20207.90
Stock Adjustments -105.1046.90148.30-15.5086.00186.90
Total Income9174.908062.508017.607240.606728.606204.70
EXPENDITURE :      
Raw Materials 3066.202917.102499.701936.201950.201882.60
Power & Fuel Cost278.60245.20193.20208.40200.20172.00
Employee Cost 1321.901204.901147.301077.40961.20826.00
Other Manufacturing Expenses 332.50381.10363.40327.30347.00307.60
Selling and Administration Expenses 1041.50958.401009.10925.30755.00813.90
Miscellaneous Expenses 335.20578.30594.40486.20280.00348.40
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure6375.906285.005807.104960.804493.604350.50
Operating Profit2799.001777.502210.502279.802235.001854.20
Interest 278.20134.9070.90233.9089.6063.90
Gross Profit2520.801642.602139.602045.902145.401790.30
Depreciation488.60478.70451.10428.90358.20293.10
Profit Before Tax2032.201163.901688.501617.001787.201497.20
Tax461.80260.20303.30164.10335.40318.30
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax41.2045.80-91.0040.00-33.9088.10
Reported Net Profit1529.20857.901476.201412.901485.701090.80
Extraordinary Items -92.41-237.64-156.95-52.6774.4434.24
Adjusted Net Profit1621.611095.541633.151465.571411.261056.56
Adjst. below Net Profit 1.80-6.90-15.30-6.00-294.40-9.60
P & L Balance brought forward9289.408796.907336.006645.705812.704731.50
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 253.00358.500.00716.60358.300.00
P & L Balance carried down10567.409289.408796.907336.006645.705812.70
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %600.00250.00350.00350.00350.00350.00
Earnings Per Share-Unit Curr15.118.3814.4213.8014.5110.65
Earnings Per Share(Adj)-Unit Curr15.118.3814.4213.8014.5110.65
Book Value-Unit Curr134.78129.30124.46109.9683.6875.64